Publications by authors named "Megan Hartranft"

Claim this Profile
T
Two cases of combination therapy with cetuximab, paclitaxel, and cisplatin for advanced head and neck cancer.
Matthew A Hoch, Kati Cousins, Ruth Nartey, Keith Riley, Megan Hartranft

J Oncol Pharm Pract· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flipped script for gefitinib: A reapproved tyrosine kinase inhibitor for first-line treatment of epidermal growth factor receptor mutation positive metastatic nonsmall cell lung cancer.
Brian S Bogdanowicz, Matthew A Hoch, Megan E Hartranft

J Oncol Pharm Pract· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.
Megan E Hartranft, Amber B Clemmons, David L DeRemer, Vamsi Kota

J Oncol Pharm Pract· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Triple Phase" Budesonide Capsules for the Treatment of Olmesartan-Induced Enteropathy.
Megan E Hartranft, Randolph E Regal

Ann Pharmacother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dicarboxylic fatty acid derivative of paclitaxel for albumin-assisted drug delivery.
Michael J Hackett, Shyamsunder Joolakanti, Megan E Hartranft, Patrick C Guley, Moo J Cho

J Pharm Sci· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis